Literature DB >> 26893134

Communication of Recurrence Risk Estimates to Patients Diagnosed With Breast Cancer.

Brian J Zikmund-Fisher1, Nancy K Janz2, Sarah T Hawley3, Kent A Griffith4, Aaron Sabolch5, Reshma Jagsi6.   

Abstract

Entities:  

Year:  2016        PMID： 26893134     DOI： 10.1001/jamaoncol.2015.6416

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

1.  Recurrence risk perception and quality of life following treatment of breast cancer.

Authors:  Sarah T Hawley; Nancy K Janz; Kent A Griffith; Reshma Jagsi; Christopher R Friese; Allison W Kurian; Ann S Hamilton; Kevin C Ward; Monica Morrow; Lauren P Wallner; Steven J Katz
Journal:  Breast Cancer Res Treat       Date:  2016-12-21       Impact factor: 4.624

2.  Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer.

Authors:  Dean A Shumway; Kent A Griffith; Sarah T Hawley; Lauren P Wallner; Kevin C Ward; Ann S Hamilton; Monica Morrow; Steven J Katz; Reshma Jagsi
Journal:  Cancer       Date:  2018-04-18       Impact factor: 6.921

3.  The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence.

Authors:  Nancy K Janz; Yun Li; Brian J Zikmund-Fisher; Reshma Jagsi; Allison W Kurian; Lawrence C An; M Chandler McLeod; Kamaria L Lee; Steven J Katz; Sarah T Hawley
Journal:  Breast Cancer Res Treat       Date:  2016-12-09       Impact factor: 4.624

4.  Estimation of Risk of Recurrence and Toxicity Among Oncologists and Patients With Resected Breast Cancer: A Quantitative Study.

Authors:  Laura Ciria-Suarez; Paula Jimenez-Fonseca; Raquel Hernández; Jacobo Rogado; Caterina Calderon
Journal:  Front Psychol       Date:  2020-10-27

5.  Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty.

Authors:  Jet W Ankersmid; Pauline E R Spronk; Anneke M Zeillemaker; Sabine Siesling
Journal:  Breast Cancer Res Treat       Date:  2022-03-13       Impact factor: 4.624
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.